Literature DB >> 18781074

Neuroaid in stroke recovery.

Charles Hua Chiang Siow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18781074     DOI： 10.1159/000155220

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  7 in total

1.  A randomized trial to assess the long-term safety of NeuroAiD among Caucasian patients with acute ischemic stroke.

Authors:  Reza Bavarsad Shahripour; Ahmad Hemati; Ana Hosseinzadeh Maleki
Journal:  Chin J Integr Med       Date:  2014-04-02       Impact factor: 1.978

2.  MLC901 during sleep deprivation rescues fear memory disruption in rats.

Authors:  Mohammad Nasehi; Ameneh Mohammadi; Mohaddeseh Ebrahimi-Ghiri; Mehrdad Hashemi; Mohammad-Reza Zarrindast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-02-28       Impact factor: 3.000

3.  Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  A A Harandi; R Abolfazli; A Hatemian; K Ghragozlee; M Ghaffar-Pour; M Karimi; S Shahbegi; H Pakdaman; M Tabasi; A L Tabatabae; A Nourian
Journal:  Stroke Res Treat       Date:  2011-06-21

4.  Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury.

Authors:  Ramesh Kumar; Ohnmar Htwe; Azmi Baharudin; Mohammad Hisam Ariffin; Shaharuddin Abdul Rhani; Kamalnizat Ibrahim; Aishah Rustam; Robert Gan
Journal:  JMIR Res Protoc       Date:  2016-12-05

5.  The Traditional Chinese Medicine MLC901 inhibits inflammation processes after focal cerebral ischemia.

Authors:  C Widmann; C Gandin; A Petit-Paitel; M Lazdunski; C Heurteaux
Journal:  Sci Rep       Date:  2018-12-24       Impact factor: 4.379

6.  Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol.

Authors:  Pavel Pilipenko; Anna Andreevna Ivanova; Yulia Vadimovna Kotsiubinskaya; Valery Feigin; Marek Majdan; Vera Naumovna Grigoryeva; Alexey Yevgenievich Khrulev
Journal:  BMJ Open       Date:  2022-04-13       Impact factor: 3.006

7.  The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients.

Authors:  Jose C Navarro; Mark C Molina; Alejandro C Baroque Ii; Johnny K Lokin
Journal:  Rehabil Res Pract       Date:  2012-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.